Shandong Keyuan Pharmaceutical Co. Ltd. A Cash Flow Reinvestment Rate
Shandong Keyuan Pharmaceutical Co. Ltd. A cash flow reinvestment rate. Shandong Keyuan Pharmaceutical Co. Ltd. A (301281) has a Cash Flow Reinvestment Rate of 16.27x as of December 2023, reinvesting CN¥602.32 Million (capex CN¥70.15 Million plus investments CN¥-532.17 Million) from operating cash flow of CN¥37.03 Million. Explore Shandong Keyuan Pharmaceutical Co. Ltd. cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Shandong Keyuan Pharmaceutical Co. Ltd. A (2021–2023)
Cash flow reinvestment rate of Shandong Keyuan Pharmaceutical Co. Ltd. A from 2021 to 2023. Historical reinvestment intensity for Shandong Keyuan Pharmaceutical Co. Ltd. A across 3 annual periods. Explore 301281 capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Shandong Keyuan Pharmaceutical Co. Ltd. A Cash Flow Reinvestment Rate by Year (2021–2023)
Shandong Keyuan Pharmaceutical Co. Ltd. A cash flow reinvestment rate by year from 2021 to 2023. Year-by-year capital reinvestment analysis for Shandong Keyuan Pharmaceutical Co. Ltd. A. For the full cash flow conversion analysis, see 301281 operating cash flow.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 16.27x | CN¥602.32 Million | CN¥37.03 Million | CN¥70.15 Million | ▲ +5958.1% |
| 2022 | 0.27x | CN¥31.11 Million | CN¥115.86 Million | CN¥31.11 Million | ▼ -30.8% |
| 2021 | 0.39x | CN¥20.19 Million | CN¥52.02 Million | CN¥20.19 Million | — |